View graph of relations
  1. 2019
  2. Published
  3. Published
  4. Published
  5. Published
    de Jong, M. J., Roosen, D., Degens, J. H. R. J., van den Heuvel, T. R. A., Romberg-Camps, M., Hameeteman, W., ... Pierik, M. J. (2019). Development and Validation of a Patient-reported Score to Screen for Mucosal Inflammation in Inflammatory Bowel Disease. Journal of Crohn's & Colitis, 13(5), 555-563. https://doi.org/10.1093/ecco-jcc/jjy196
  6. Published
  7. Published
  8. Published
    Simsek, M., Hoentjen, F., Oldenburg, B., Ponsioen, C. Y., van der Woude, J., van der Meulen, A. E., ... de Boer, N. K. (2019). Off-label drug use in patients with inflammatory bowel disease: a national survey among tertiary care centres. Journal of Crohn's & Colitis, 13, S472-S472. https://doi.org/10.1093/ecco-jcc/jjy222.826
  9. Published
  10. 2018
  11. Published
  12. Published
  13. Published
    Dutch Initiative Crohn Colitis ICC; Dutch Head Neck Soc; PALGA Grp; IBD HNC Grp, Nissen, L. H. C., Derikx, L. A. A. P., Jacobs, A. M. E., van Herpen, C. M., Kievit, W., ... Hoentjen, F. (2018). Risk Factors and Clinical Outcomes of Head and Neck Cancer in Inflammatory Bowel Disease: A Nationwide Cohort Study. Inflammatory Bowel Diseases, 24(9), 2015-2026. https://doi.org/10.1093/ibd/izy096
  14. Published
  15. Published
    Int IBD Genetics Consortium, Momozawa, Y., Dmitrieva, J., Theatre, E., Deffontaine, V., Rahmouni, S., ... Zhang, H. (2018). IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes. Nature Communications, 9, [2427]. https://doi.org/10.1038/s41467-018-04365-8
  16. Published
    Severs, M., Spekhorst, L. M., Mangen, M-J. J., Dijkstra, G., Lowenberg, M., Hoentjen, F., ... Fidder, H. H. (2018). Sex-Related Differences in Patients With Inflammatory Bowel Disease: Results of 2 Prospective Cohort Studies. Inflammatory Bowel Diseases, 24(6), 1298-1306. https://doi.org/10.1093/ibd/izy004
  17. Published
    Dutch Initiative Crohn Colitis ICC; Parelsnoer Inst, Visschedijk, M. C., Spekhorst, L. M., Cheng, S-C., van Loo, E. S., Jansen, B. H. D., ... Festen, E. A. M. (2018). Genomic and Expression Analyses Identify a Disease-Modifying Variant for Fibrostenotic Crohn's Disease. Journal of Crohn's & Colitis, 12(5), 582-588. https://doi.org/10.1093/ecco-jcc/jjy001
  18. Published
  19. Published
  20. Published
  21. Published
  22. 2017
  23. Published
    Spekhorst, L. M., Oldenburg, B., van Bodegraven, A. A., de Jong, D. J., Imhann, F., van der Meulen-de Jong, A. E., ... Parelsnoer Inst Dutch Initiative C (2017). Prevalence of- and risk factors for work disability in Dutch patients with inflammatory bowel disease. World Journal of Gastroenterology, 23(46), 8182-8192. https://doi.org/10.3748/wjg.v23.i46.8182
  24. Published
    Spekhorst, L. M., Severs, M., de Boer, N. K. H., Festen, E. A. M., Fidder, H. H., Hoentjen, F., ... Dutch Initiative Crohn and Colitis (2017). The Impact of Ethnicity and Country of Birth on Inflammatory Bowel Disease Phenotype: a Prospective Cohort Study. Journal of Crohn's & Colitis, 11(12), 1463-1470. https://doi.org/10.1093/ecco-jcc/jjx098
  25. Published
    Spekhorst, L. M., Imhann, F., Festen, E. A. M., van Bodegraven, A. A., de Boer, N. K. H., Bouma, G., ... Dutch Initiative Crohn and Colitis (2017). Cohort profile: design and first results of the Dutch IBD Biobank: a prospective, nationwide biobank of patients with inflammatory bowel disease. BMJ Open, 7(11), [016695]. https://doi.org/10.1136/bmjopen-2017-016695
  26. Published
    Nissen, L. H. C., Pierik, M., Derikx, L. A. A. P., de Jong, E., Kievit, W., van den Heuvel, T. R. A., ... IBD & Melanoma Grp (2017). Risk Factors and Clinical Outcomes in Patients with IBD with Melanoma. Inflammatory Bowel Diseases, 23(11), 2018-2026. https://doi.org/10.1097/MIB.0000000000001191
  27. Published
  28. Published
  29. Published
    Severs, M., Mangen, M-J. J., Fidder, H. H., van der Valk, M. E., van der Have, M., van Bodegraven, A. A., ... Dutch Initiative Crohn and Colitis (2017). Clinical Predictors of Future Nonadherence in Inflammatory Bowel Disease. Inflammatory Bowel Diseases, 23(9), 1568-1576. https://doi.org/10.1097/MIB.0000000000001201
  30. Published
  31. Published
  32. Published
  33. Published
  34. Published
  35. Published
    de Jong, M., van der Meulen-de Jong, A., Romberg-Camps, M., Degens, J., Becx, M., Markus, T., ... Pierik, M. (2017). Development and Feasibility Study of a Telemedicine Tool for All Patients with IBD: MyIBDcoach. Inflammatory Bowel Diseases, 23(4), 485-493. https://doi.org/10.1097/MIB.0000000000001034
  36. Published
    Severs, M., Mangen, M-J. J., van der Valk, M. E., Fidder, H. H., Dijkstra, G., van der Have, M., ... Dutch Initiative Crohn and Colitis (2017). Smoking is Associated with Higher Disease-related Costs and Lower Health-related Quality of Life in Inflammatory Bowel Disease. Journal of Crohn's & Colitis, 11(3), 342-352. https://doi.org/10.1093/ecco-jcc/jjw160
  37. Published
  38. Published
  39. Published
  40. 2016
  41. Published
    Nissen, L. H. C., Assendorp, E. L., van der Post, R. S., Derikx, L. A. A. P., de Jong, D. J., Kievit, W., ... Nagtegaal, I. D. (2016). Impaired Gastric Cancer Survival in Patients with Inflammatory Bowel Disease. Journal of Gastrointestinal and Liver Diseases, 25(4), 431-440. https://doi.org/10.15403/jgld.2014.1121.254.nis
  42. Published
  43. Published
  44. Published
  45. Published
  46. Published
  47. Published
  48. Published
  49. Published
  50. Published
  51. Published
  52. Published
    Severs, M., van Erp, S. J. H., van der Valk, M. E., Mangen, M. J., Fidder, H. H., van der Have, M. M., ... Oldenburg, B. (2016). Smoking is Associated With Extra-intestinal Manifestations in Inflammatory Bowel Disease. Journal of Crohn's & Colitis, 10(4), 455-461. https://doi.org/10.1093/ecco-jcc/jjv238
  53. Published
  54. 2015
  55. Published
  56. Published
    ten Have, M., Fidder, H. H., Leenders, M., Kaptein, A. A., van der Valk, M. E., van Bodegraven, A. A., ... Oldenburg, B. (2015). Self-reported Disability in Patients with Inflammatory Bowel Disease Largely Determined by Disease Activity and Illness Perceptions. Inflammatory Bowel Diseases, 21(2), 369-377. https://doi.org/10.1097/MIB.0000000000000278
  57. Published
    Derikx, L. A., Nissen, L. H., Drenth, J. P., van Herpen, C. M., Kievit, W., Verhoeven, R. H., ... Hoentjen, F. (2015). Better survival of renal cell carcinoma in patients with inflammatory bowel disease. Oncotarget. https://doi.org/10.18632/oncotarget.5186
  58. Published
    van der Valk, M. E., Mangen, M. J., Severs, M., ten Have, M., Dijkstra, G., van Bodegraven, A. A., ... Oldenburg, B. (2015). Comparison of Costs and Quality of Life in Ulcerative Colitis Patients with an Ileal Pouch-Anal Anastomosis, Ileostomy and Anti-TNFα Therapy. Journal of Crohn's & Colitis, 9(11), 1016-1023. https://doi.org/10.1093/ecco-jcc/jjv134
  59. Published
  60. Published
  61. Published
    Coenen, M. J., de Jong, D. J., van Marrewijk, C. J., Derijks, L. J., Vermeulen, S. H., Wong, D. R., ... Franke, B. (2015). Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease. Gastroenterology, 149(4), 907-917 e907. https://doi.org/10.1053/j.gastro.2015.06.002
  62. Published
  63. Published
    de Groof, E. J., Buskens, C. J., Ponsioen, C. Y., Dijkgraaf, M. G., D'Haens, G. R., Srivastava, N., ... Bemelman, W. A. (2015). Multimodal treatment of perianal fistulas in Crohn's disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial. Trials, 16(1), [366]. https://doi.org/10.1186/s13063-015-0831-x
  64. Published
  65. 2014
  66. Published
  67. Published
  68. Published
  69. Published
    Wong, D. R., Pierik, M., Seinen, M. L., van Bodegraven, A. A., Gilissen, L. P. L., Bus, P., ... Hooymans, P. M. (2014). The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients. Journal of Crohn's & Colitis, 8(2), 120-128. https://doi.org/10.1016/j.crohns.2013.07.004
  70. Published
  71. Published
  72. Published
  73. Published
    van der Have, M. M., Mangen, M. J., van der Valk, M. E., Smeets, H. M., van Bodegraven, A., Dijkstra, G., ... Oldenburg, B. (2014). Effect of Aging on Healthcare Costs of Inflammatory Bowel Disease: A Glimpse into the Future. Inflammatory Bowel Diseases, 20(4), 637-645. https://doi.org/10.1097/01.MIB.0000442677.55051.03
  74. Published
  75. Published
    van der Valk, M. E., Mangen, M. J., Leenders, M., Dijkstra, G., van Bodegraven, A. A., Fidder, H. H., ... Oldenburg, B. (2014). Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study. Gut, 63(1), 72-79. https://doi.org/10.1136/gutjnl-2012-303376
  76. 2013
  77. Published
  78. Published
  79. Published
    Flourie, B., Hagege, H., Tucat, G., Maetz, D., Hebuterne, X., Kuyvenhoven, J. P., ... Aoucheta, D. (2013). Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitis. Alimentary Pharmacology & Therapeutics, 37(8), 767-775. https://doi.org/10.1111/apt.12266
  80. Published
    van Schaik, F. D., Mooiweer, E., ten Have, M., Belderbos, T. D., ten Kate, F. J., Offerhaus, G. J., ... Oldenburg, B. (2013). Adenomas in Patients with Inflammatory Bowel Disease Are Associated with an Increased Risk of Advanced Neoplasia. Inflammatory Bowel Diseases, 19(2), 342-349. https://doi.org/10.1097/MIB.0b013e318286f771
  81. Published
  82. Published
  83. 2012
  84. Published
  85. Published
  86. Published
  87. 2011
  88. Published
  89. Published
    Katsanos, K. H., Tatsioni, A., Pedersen, N., Shuhaibar, M., Ramirez, V. H., Politi, P., ... Tsianos, E. V. (2011). Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European Collaborative follow-up study. Journal of Crohn's & Colitis, 5(5), 430-442. https://doi.org/10.1016/j.crohns.2011.04.013
  90. Published
    Vos, A. C., Bakkal, N., Minnee, R. C., Casparie, M. K., de Jong, D. J., Dijkstra, G., ... Hommes, D. W. (2011). Risk of malignant lymphoma in patients with inflammatory bowel diseases: a Dutch nationwide study. Inflammatory Bowel Diseases, 17(9), 1837-1845. https://doi.org/10.1002/ibd.21582
  91. Published
  92. Published
    Baars, J. E., Kuipers, E. J., Dijkstra, G., Hommes, D. W., de Jong, D. J., Stokkers, P. C., ... van der Woude, C. J. (2011). Malignant transformation of perianal and enterocutaneous fistulas is rare: results of 17 years of follow-up from The Netherlands. Scandinavian Journal of Gastroenterology, 46(3), 319-325. https://doi.org/10.3109/00365521.2010.536251
  93. Published
    Zelinkova, Z., de Haar, C., De Ridder, L., Pierik, M. J., Kuipers, E. J., Peppelenbosch, M. P., & van der Woude, C. J. (2011). High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy. Alimentary Pharmacology & Therapeutics, 33(9), 1053-1058. https://doi.org/10.1111/j.1365-2036.2011.04617.x
  94. 2010
  95. Published
  96. 2009
  97. Published
  98. Published
    Bodelier, A. G., Heijckmann, C., Hameeteman, W., De Boer, E., Jonkers, D. M. A. E., Masclee, A. A. M., & Pierik, M. J. (2009). Bone Mineral Density in IBD: A 5-Year Follow-Up Study. Gastroenterology, 136(5), A196-A196.
  99. Published
    Bueno de Mesquita, M., Ferrante, M., Henckaerts, L., Joossens, M., Janssens, V., Hlavaty, T., ... Hoffman, I. (2009). Clustering of (auto)immune diseases with early-onset and complicated inflammatory bowel disease. European Journal of Pediatrics, 168(5), 575-583. https://doi.org/10.1007/s00431-008-0798-7
  100. Published
  101. 2007
  102. Published
  103. Published
    Ferrante, M., Henckaerts, L., Joossens, M., Pierik, M. J., Joossens, S., Dotan, N., ... Vermeire, S. (2007). New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut, 56(10), 1394-1403. https://doi.org/10.1136/gut.2006.108043
  104. Published
  105. Published
  106. 2005
  107. Published
    Pierik, M. J., de Hertogh, G., Vermeire, S., van Assche, G., van Eyken, P., Joossens, S., ... Geboes, K. (2005). Epithelioid granulomas, pattern recognition receptors, and phenotypes of Crohn's disease. Gut, 54(2), 223-227. https://doi.org/10.1136/gut.2004.042572
  108. Published